Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2011-04-28 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
110428 - Acquisition of own shares_ENG.pdf
Transaction in Own Shares Classification · 99% confidence The document explicitly details the 'Acquisition of own shares in the framework of employees' long-term incentive plans' and provides a table showing the dates, amounts, and prices of UCB shares acquired on the Brussels stock exchange. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document is a specific regulatory disclosure regarding share repurchases/acquisitions, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2011-04-28 English
110428 - Acquisition of own shares_FR.pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "Acquisition d'actions propres dans le cadre de rémunérations variables à long terme du personnel" (Acquisition of own shares under long-term variable remuneration for personnel). It explicitly states that UCB acquired a specific number of its own shares on the Brussels stock exchange and details the dates and prices. This action directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The document is short and appears to be a regulatory disclosure of this specific transaction, not a general announcement of a report (RPA) or a broad regulatory filing (RNS).
2011-04-28 French
110428 - Acquisition of own shares_NL.pdf
Transaction in Own Shares Classification · 99% confidence The document text explicitly details the 'Aankoop van eigen aandelen' (Purchase of own shares) conducted by UCB on specific dates in April 2011, including the number of shares and the price. This activity directly corresponds to the definition of a company buying back or selling its own shares. This matches filing type 'Transaction in Own Shares' (POS). The document is a formal announcement regarding this specific corporate action.
2011-04-28 Dutch
Q1 2011 Interim report_ENG.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report for the first quarter of 2011' and provides detailed financial performance metrics, including revenue, EBITDA, and core earnings per share, along with operational updates on product lines and R&D. It contains substantive financial data and analysis for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2011
2011-04-28 English
Q1 2011 Interim report FR.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a quarterly financial update from UCB for the first quarter of 2011. It provides detailed financial performance metrics (revenue, EBITDA, EPS), product-specific sales data, R&D updates, and financial outlooks. It is not a mere announcement of a report (RPA) because it contains substantive financial data and analysis. It fits the definition of an Interim/Quarterly Report (IR) as it covers a period shorter than a full fiscal year and provides comprehensive financial results. Q1 2011
2011-04-28 French
Q1 2011 Interim report_NL.pdf
Interim / Quarterly Report Classification · 100% confidence The document is an 'Interimverslag' (Interim Report) for the first quarter of 2011 for UCB. It contains detailed financial performance data, including revenue figures, EBITDA, and earnings per share, as well as operational updates on product launches and R&D. It is not a mere announcement of a report, but the report itself, containing substantive financial analysis and data for a period shorter than a full fiscal year. Q1 2011
2011-04-28 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.